IL15 and breast cancer: (106), C57BL/6 mice receiving IL-15 via intravenous injection or harboring IL-15 transgenes exhibited a tenfold reduction in breast cancer metastasis compared to controls, likely due to enhanced NK cell cytotoxicity.